Only in the HER-2-enriched subtype, CD204 expression was higher in stage III-IV than in stage I-II (Figure 1D–1G), further suggesting the diverse roles of CD204 in different breast cancer subtypes. This evidence concerns the gene MSR1 and breast cancer.